![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
David Sallman: Early Results of 5F9 in AML and MDS (American Society of Hematology) View |
![]() |
David Sallman: Magrolimab Plus Azacitidine Effective in MDS and AML (American Society of Hematology) View |
![]() |
Checkpoint inhibitor combination approaches for AML/MDS: an update (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View |
![]() |
The Role of BMT in Treatment-Related MDS and AML (AAMDSIF) View |
![]() |
MDS and AML Biology (Co-Chair Summary) (AAMDSIF) View |
![]() |
Predicting Prognosis in Myelodysplastic Syndromes (American Society of Hematology) View |
![]() |
New and emerging drug targets for older AML patients (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View |
![]() |
The role of MRD in AML (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View |
![]() |
Hu5F9 plus rituximab to overcome resistance in refractory lymphoma (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View |
![]() |
Novel immunotherapy 5F9+rituximab well tolerated with rapid and durable responses in R/R DLBCL a... (ecancer) View |